You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Related Community Videos on Diabetes Health TV
VITAZEST® Vitamin and Fruit Enriched Water
Stylish and Fashionable Testing Cases
Peer Support from DiabetesSisters
Popular Professional Issues Articles
Highly Recommended Professional Issues Articles
Dental researchers are reporting that resolvins, products derived from omega-3 fatty acids, may have the ability to restore the soft tissue and even bone lost in periodontal (gum) disease.
0 comments - May 7, 2009 -
Voglibose*, a generic drug often used in combination with sulfonylureas to control blood glucose levels, appears to delay or even prevent the onset of diabetes in people who are predisposed to the disease.
6 comments - May 1, 2009 -
The Robert Wood Johnson Foundation (RWJF) has issued a call for proposals through its national program, Project HealthDesign: Rethinking the Power and Potential of Personal Health Records. Grant recipients will work to assess and test the potential of "observations of daily living" (ODLs) to help patients and physicians better manage chronic illnesses.
0 comments - May 1, 2009 -
When Smiths Medical announced in late March that it was discontinuing the manufacture and sales of its Deltec Cozmo insulin pumps, the company's annual sales of that product were about $36 million. In contrast, Medtronic, manufacturer of the Minimed line of insulin pumps reported sales of $727 million in the nine months from April 2008 to January 2009.
8 comments - Apr 29, 2009 -
Diabetes Health has joined the social networking sphere. Join us as a fan on Facebook, talk to us on Twitter, and subscribe to our RSS feed. Publisher and Editor-in-Chief, Nadia Al-Samarrie wants to hear your thoughts and she'll be reading what you have to say with great interest.
1 comment - Apr 28, 2009 -
Results from DURATION-2, a 26-week test comparing the diabetic drugs Januvia, Actos, and experimental long-acting Byetta (Byetta LAR) show that Byetta produced lower A1c's and more weight loss than the other two drugs.
5 comments - Apr 15, 2009 -
Buoyed by its recent successful phase 1 human clinical trial of a patch that delivers basal insulin through the skin, Atlanta-based Altea Therapeutics says it will work with Eli Lilly and Company and Amylin Pharmaceuticals, Inc., to develop a daily transdermal patch that deliver sustained levels of Byetta (exenatide). The patch, in a 12- and a 24-hour form, will use the company's proprietary PassPort Transdermal Delivery System. Lilly and Amylin will fund all development, manufacturing, and marketing activities for the product.
2 comments - Apr 7, 2009 -
A new research report by the Pacific Research Institute (PRI) reviews three decades of the Food and Drug Administration's performance and concludes that the agency is over-funded, over-staffed, and denies hundreds of thousands of Americans timely access to new medicines. Leviathan's Drug Problem: The Federal Monopoly of Pharmaceutical Regulation and Its Deadly Cost was authored by John R. Graham, Director of Health Care Studies at PRI.
5 comments - Apr 7, 2009 -
Last week we published an article about how the CDC says too many people are still smoking. The federal government has a Healthy People 2010 goal of reducing adult smoking rates to 12 percent or less by 2010. Of the 50 states, only Utah has thus far achieved that goal.
1 comment - Apr 2, 2009 -
Canadian scientists studying the effects of glucose on cellular aging have discovered an unusual effect that could change how doctors treat diabetes and even address the human lifespan.
2 comments - Apr 1, 2009 -
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.